Article
Effect of docosahexaenoic acid supplementation on the macular function of patients with Best vitelliform macular dystrophy: randomized clinical trial.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie - 1 Oct 2010
Lee Thomas K M, Clandinin M Thomas, Hébert Marc, MacDonald Ian M
Abstract excerpt
OBJECTIVE: Best disease is a slowly progressive macular dystrophy that typically has an onset in early childhood. Multiple lines of evidence suggest that dietary docosahexaenoic acid (DHA) protects against the development of macular degeneration. Our trial tested the effect of an oral supplement...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
